| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 230.06 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 164.826 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 158.161 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 206.249 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 195.401 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 168.962 | 82 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 173.023 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 202.889 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 214.156 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 147.259 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 228.893 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 233.613 | 85 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 234.272 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 177.286 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 221.948 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 226.209 | 85 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 183.837 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 197.669 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 236.918 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 204.387 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 199.235 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 203.667 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 178.443 | 82 |